Diltiazem
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Diltiazem is a benzothiazepine-type non-dihydropyridine calcium channel blocker that affects both vascular smooth muscle and cardiac conduction tissue. It is used for hypertension, angina, and rate control in atrial fibrillation/flutter. Its dual action on vessels and the AV node makes it versatile.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Diltiazem is a benzothiazepine-type non-dihydropyridine calcium channel blocker that affects both vascular smooth muscle and cardiac conduction tissue. NutriStack rates the supporting evidence as strong. Common adult dosing is 120–360 mg daily (extended-release once daily; immediate-release 3–4 times daily) (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 10 sources.
- Bradycardia
- Peripheral edema
- Dizziness
- Severe sinus bradycardia or sick sinus syndrome without pacemaker
- Second- or third-degree AV block without pacemaker6
The bottom line
Evidence rating strong. Most-documented uses: effective blood pressure reduction, rate control in atrial fibrillation/flutter, angina relief including vasospastic (prinzmetal) angina. 10 sources indexed (2018–2024), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Inhibits L-type calcium channels in both vascular smooth muscle and cardiac tissue. Causes vasodilation (reducing blood pressure), slows conduction through the AV node (rate control), and reduces myocardial contractility and oxygen demand. Also has coronary vasodilatory properties, making it effective for vasospastic angina.6,7
Dosing & protocol.
Extended-release formulations can be taken with or without food; immediate-release absorption is not significantly affected by food
Full safety detail.
Side effects
- Bradycardia
- Peripheral edema
- Dizziness
- Headache
- Constipation
- Flushing
- AV block (dose-dependent)
Contraindications
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
5- 1Intravenous Diltiazem Versus Metoprolol in Acute Rate Control of Atrial Fibrillation/Flutter and Rapid Ventricular Response: A Meta-Analysis of Randomized and Observational StudiesPMIDBolton A, Paudel B, Adhaduk M et al. · American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024
Bolton A, Paudel B, Adhaduk M et al.. Intravenous Diltiazem Versus Metoprolol in Acute Rate Control of Atrial Fibrillation/Flutter and Rapid Ventricular Response: A Meta-Analysis of Randomized and Observational Studies. American journal of cardiovascular drugs : drugs, devices, and other interventions. 2024
- 2Comparison of the Effectiveness and Safety of Metoprolol and Diltiazem in Atrial Fibrillation With Rapid Ventricular Rate Patients: A Systematic Review and Meta-AnalysisPMIDMayow AH, Sinha T, Ahmad M et al. · Cureus · 2024
Mayow AH, Sinha T, Ahmad M et al.. Comparison of the Effectiveness and Safety of Metoprolol and Diltiazem in Atrial Fibrillation With Rapid Ventricular Rate Patients: A Systematic Review and Meta-Analysis. Cureus. 2024
- 3Efficacy and Safety of Intravenous Diltiazem Versus Metoprolol in the Management of Atrial Fibrillation with Rapid Ventricular Response in the Emergency Department: A Comprehensive Umbrella Review of Systematic Reviews and Meta-analysesPMIDJaya F, Afzal M, Anusha F et al. · The Journal of innovations in cardiac rhythm management · 2024
Jaya F, Afzal M, Anusha F et al.. Efficacy and Safety of Intravenous Diltiazem Versus Metoprolol in the Management of Atrial Fibrillation with Rapid Ventricular Response in the Emergency Department: A Comprehensive Umbrella Review of Systematic Reviews and Meta-analyses. The Journal of innovations in cardiac rhythm management. 2024
- 4Comparison of diltiazem and metoprolol for atrial fibrillation with rapid ventricular rate: Systematic review and meta-analysisPMIDSharda SC, Bhatia MS · Indian heart journal · 2022
Sharda SC, Bhatia MS. Comparison of diltiazem and metoprolol for atrial fibrillation with rapid ventricular rate: Systematic review and meta-analysis. Indian heart journal. 2022
- 5Perioperative diltiazem or nitroglycerin in on-pump coronary artery bypass: A systematic review and network meta-analysisPMIDHu Y, Yang X, Zhang L et al. · PloS one · 2018
Hu Y, Yang X, Zhang L et al.. Perioperative diltiazem or nitroglycerin in on-pump coronary artery bypass: A systematic review and network meta-analysis. PloS one. 2018
Reference material
5- 6ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to ACE inhibitor or calcium channel blocker vs diuretic (ALLHAT). JAMA. 2002.Source linkedPMID
- 7Abernethy DR and Schwartz JB. Calcium-antagonist drugs. N Engl J Med. 1999.Source linkedPMID
- 8Aygin D et al. Evaluation of Surgical and Conservative Approaches in the Treatment of Anal Fissure: A Systematic Review. Acta Gastroenterol Belg. 2025.Source linkedPMID
- 9Hintze TD, Downing JV, Acquisto NM et al.. Metoprolol vs diltiazem for atrial fibrillation with rapid ventricular rate: Systematic review and meta-analysis of adverse events. The American journal of emergency medicine. 2025Source linkedPMID
- 10Pil E, Levy M, Chizmar T et al.. Efficacy and Safety of Prehospital Diltiazem. Prehospital emergency care. 2024Source linkedPMID
Common questions.
Quick answers about Diltiazem, drawn from the data on this page.
What is Diltiazem?
Diltiazem is a benzothiazepine-type non-dihydropyridine calcium channel blocker that affects both vascular smooth muscle and cardiac conduction tissue. It is used for hypertension, angina, and rate control in atrial fibrillation/flutter. Its dual action on vessels and the AV node makes it versatile.
What is Diltiazem used for?
Commonly cited benefits of Diltiazem include: Effective blood pressure reduction; Rate control in atrial fibrillation/flutter; Angina relief including vasospastic (Prinzmetal) angina; Coronary vasodilation. NutriStack rates the overall evidence as strong.
What is a typical dose of Diltiazem?
A typical adult dose of Diltiazem is 120–360 mg daily (extended-release once daily; immediate-release 3–4 times daily) (as prescribed by your physician). The commonly recommended form is Extended-release capsule or tablet preferred for hypertension; immediate-release or IV for acute rate control. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Diltiazem?
Reported side effects include bradycardia, peripheral edema, dizziness, headache, constipation, flushing. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Diltiazem?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Diltiazem in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.